199 related articles for article (PubMed ID: 36707502)
1. NF-YAl drives EMT in Claudin
Londero M; Gallo A; Cattaneo C; Ghilardi A; Ronzio M; Del Giacco L; Mantovani R; Dolfini D
Cell Death Dis; 2023 Jan; 14(1):65. PubMed ID: 36707502
[TBL] [Abstract][Full Text] [Related]
2. NF-YA Overexpression in Lung Cancer: LUSC.
Bezzecchi E; Ronzio M; Dolfini D; Mantovani R
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31744190
[TBL] [Abstract][Full Text] [Related]
3. Overexpression and alternative splicing of NF-YA in breast cancer.
Dolfini D; Andrioletti V; Mantovani R
Sci Rep; 2019 Sep; 9(1):12955. PubMed ID: 31506469
[TBL] [Abstract][Full Text] [Related]
4. The Switch from NF-YAl to NF-YAs Isoform Impairs Myotubes Formation.
Libetti D; Bernardini A; Sertic S; Messina G; Dolfini D; Mantovani R
Cells; 2020 Mar; 9(3):. PubMed ID: 32214056
[TBL] [Abstract][Full Text] [Related]
5. NF-Y subunits overexpression in gastric adenocarcinomas (STAD).
Gallo A; Ronzio M; Bezzecchi E; Mantovani R; Dolfini D
Sci Rep; 2021 Dec; 11(1):23764. PubMed ID: 34887475
[TBL] [Abstract][Full Text] [Related]
6. NF-YA Overexpression in Lung Cancer: LUAD.
Bezzecchi E; Ronzio M; Semeghini V; Andrioletti V; Mantovani R; Dolfini D
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32075093
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients.
Belluti S; Semeghini V; Rigillo G; Ronzio M; Benati D; Torricelli F; Reggiani Bonetti L; Carnevale G; Grisendi G; Ciarrocchi A; Dominici M; Recchia A; Dolfini D; Imbriano C
J Exp Clin Cancer Res; 2021 Nov; 40(1):362. PubMed ID: 34782004
[TBL] [Abstract][Full Text] [Related]
8. The NF-Y splicing signature controls hybrid EMT and ECM-related pathways to promote aggressiveness of colon cancer.
Rigillo G; Belluti S; Campani V; Ragazzini G; Ronzio M; Miserocchi G; Bighi B; Cuoghi L; Mularoni V; Zappavigna V; Dolfini D; Mercatali L; Alessandrini A; Imbriano C
Cancer Lett; 2023 Jul; 567():216262. PubMed ID: 37307894
[TBL] [Abstract][Full Text] [Related]
9. NF-Y Subunits Overexpression in HNSCC.
Bezzecchi E; Bernardini A; Ronzio M; Miccolo C; Chiocca S; Dolfini D; Mantovani R
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34208636
[TBL] [Abstract][Full Text] [Related]
10. NF-YA splice variants have different roles on muscle differentiation.
Basile V; Baruffaldi F; Dolfini D; Belluti S; Benatti P; Ricci L; Artusi V; Tagliafico E; Mantovani R; Molinari S; Imbriano C
Biochim Biophys Acta; 2016 Apr; 1859(4):627-38. PubMed ID: 26921500
[TBL] [Abstract][Full Text] [Related]
11. Discovery, characterization and potential roles of a novel NF-YAx splice variant in human neuroblastoma.
Cappabianca L; Farina AR; Di Marcotullio L; Infante P; De Simone D; Sebastiano M; Mackay AR
J Exp Clin Cancer Res; 2019 Dec; 38(1):482. PubMed ID: 31805994
[TBL] [Abstract][Full Text] [Related]
12. NF-Y Overexpression in Liver Hepatocellular Carcinoma (HCC).
Bezzecchi E; Ronzio M; Mantovani R; Dolfini D
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271832
[TBL] [Abstract][Full Text] [Related]
13. NF-YA isoforms with alternative splicing of exon-5 in Aves.
Gallo A; Dolfini D; Bernardini A; Gnesutta N; Mantovani R
Genomics; 2023 Sep; 115(5):110694. PubMed ID: 37536396
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic transformation-dependent expression of a transcription factor NF-Y subunit.
Gu Z; Kuntz-Simon G; Rommelaere J; Cornelis J
Mol Carcinog; 1999 Apr; 24(4):294-9. PubMed ID: 10326866
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of NF-YA splicing isoforms and Lamin A status in low grade endometrial cancer.
Cicchillitti L; Corrado G; Carosi M; Dabrowska ME; Loria R; Falcioni R; Cutillo G; Piaggio G; Vizza E
Oncotarget; 2017 Jan; 8(5):7935-7945. PubMed ID: 27974701
[TBL] [Abstract][Full Text] [Related]
16. Dual transcriptional control of claudin-11 via an overlapping GATA/NF-Y motif: positive regulation through the interaction of GATA, NF-YA, and CREB and negative regulation through the interaction of Smad, HDAC1, and mSin3A.
Lui WY; Wong EW; Guan Y; Lee WM
J Cell Physiol; 2007 Jun; 211(3):638-48. PubMed ID: 17226765
[TBL] [Abstract][Full Text] [Related]
17. The short isoform of NF-YA belongs to the embryonic stem cell transcription factor circuitry.
Dolfini D; Minuzzo M; Pavesi G; Mantovani R
Stem Cells; 2012 Nov; 30(11):2450-9. PubMed ID: 22969033
[TBL] [Abstract][Full Text] [Related]
18. Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer.
Fici P; Gallerani G; Morel AP; Mercatali L; Ibrahim T; Scarpi E; Amadori D; Puisieux A; Rigaud M; Fabbri F
Oncotarget; 2017 Jan; 8(2):2423-2436. PubMed ID: 27911856
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ERalpha-mediated trans-activation of human coagulation factor XII gene by heteromeric transcription factor NF-Y.
Farsetti A; Narducci M; Moretti F; Nanni S; Mantovani R; Sacchi A; Pontecorvi A
Endocrinology; 2001 Aug; 142(8):3380-8. PubMed ID: 11459781
[TBL] [Abstract][Full Text] [Related]
20. The transcription factor NF-YA is crucial for neural progenitor maintenance during brain development.
Yamanaka T; Kurosawa M; Yoshida A; Shimogori T; Hiyama A; Maity SN; Hattori N; Matsui H; Nukina N
J Biol Chem; 2024 Feb; 300(2):105629. PubMed ID: 38199563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
